Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects (Q60018974)
Jump to navigation
Jump to search
scientific article published on 13 June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects |
scientific article published on 13 June 2006 |
Statements
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects (English)
Alessandra Bura
Michel Azizi
Véronique Remones
Catherine Goyenvalle
Martine Aiach
Philippe Lechat